Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 50039906
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 4.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 4.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 4.50E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 5.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 5.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 5.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 6.00E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 6.10E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 6.20E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 6.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 6.60E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 6.90E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 7.50E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 7.50E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 8.00E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 8.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 8.50E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 8.60E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 9.00E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 9.40E+4nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.14E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.20E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.24E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.41E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.41E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.78E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 1.85E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 2.30E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 2.59E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 2.82E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair
TargetChondroitin sulfate N-acetylgalactosaminyltransferase 1(Human)
Piramal Healthcare
Curated by ChEMBL
Piramal Healthcare
Curated by ChEMBL
Affinity DataIC50: 4.58E+5nMAssay Description:Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation countingMore data for this Ligand-Target Pair